Treace Medical CFO granted 100,000 PSUs

Treace Medical Concepts, Inc. Chief Financial Officer Mark Hair reported an equity compensation grant of 100,000 performance stock units.

Rhea-AI Filing Summary

Treace Medical Concepts, Inc. Chief Financial Officer Mark Hair reported an equity compensation grant of 100,000 performance stock units. Each PSU entitles him to one share of common stock upon vesting, reflecting a non-cash, compensation-related acquisition rather than an open-market purchase.

The PSUs were earned after the Compensation Committee certified achievement of a performance goal and will vest 25% on April 15, 2026 and 25% on each February 15 of 2027, 2028 and 2029, subject to his continued service. Following this award, he directly holds 963,549 shares of common stock, which include 811,691 restricted stock units.

Insider Trade Summary

Grant/Award: 100,000 shares

Grant/Award 1 txn

Insider Hair Mark

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	100,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 963,549 shares (Direct)

Footnotes (2)

1. F1. Represents performance stock units ("PSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs were earned upon the Compensation Committee's certification of accomplishment of a performance goal and will vest 25% on April 15, 2026 and 25% on each February 15 of 2027, 2028, and 2029, subject to the Reporting Person's continued service through the applicable vesting date.
2. F2. Includes 811,691 restricted stock units.

Key Figures

Performance stock units granted: 100,000 PSUs Vesting proportion per tranche: 25% Shares held after transaction: 963,549 shares +1 more

4 metrics

Performance stock units granted 100,000 PSUs Grant to CFO Mark Hair on April 1, 2026

Vesting proportion per tranche 25% Each of four vesting dates from 2026 to 2029

Shares held after transaction 963,549 shares Total common stock directly held following grant

Restricted stock units included 811,691 RSUs Portion of total direct holdings comprised of RSUs

Key Terms

performance stock units ("PSUs"), restricted stock units, Compensation Committee, vesting

4 terms

performance stock units ("PSUs") financial

"Represents performance stock units ("PSUs") for which the Reporting Person is entitled to receive one (1) share"

restricted stock units financial

"Includes 811,691 restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Compensation Committee financial

"The PSUs were earned upon the Compensation Committee's certification of accomplishment"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

vesting financial

"for each PSU upon vesting. The PSUs were earned upon the Compensation Committee's certification"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Treace Medical (TMCI) CFO Mark Hair report?

Mark Hair reported receiving 100,000 performance stock units as equity compensation. These units convert into common stock upon vesting, reflecting a grant or award acquisition rather than an open-market share purchase or sale.

How many performance stock units did TMCI grant to its CFO and how do they convert?

The CFO was granted 100,000 performance stock units. Each PSU entitles him to receive one share of Treace Medical’s common stock upon vesting, creating a potential one-for-one increase in common shares if all units ultimately vest.

What is the vesting schedule for the TMCI CFO’s new performance stock units?

The performance stock units vest over four installments. They vest 25% on April 15, 2026, and 25% on each February 15 of 2027, 2028 and 2029, contingent on the CFO’s continued service through each vesting date.

How many Treace Medical (TMCI) shares does the CFO hold after this Form 4 transaction?

After the reported grant, the CFO directly holds 963,549 shares of common stock. This total includes 811,691 restricted stock units, which represent shares subject to vesting conditions rather than fully unrestricted stock.

What role did the Compensation Committee play in the TMCI CFO’s PSU grant?

The performance stock units were earned after the Compensation Committee certified that a specified performance goal was achieved. Only after this certification did the PSUs become earned and subject to the time-based vesting schedule through 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 09:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hair Mark

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		100,000(1)	A	$0	963,549(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance stock units ("PSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs were earned upon the Compensation Committee's certification of accomplishment of a performance goal and will vest 25% on April 15, 2026 and 25% on each February 15 of 2027, 2028, and 2029, subject to the Reporting Person's continued service through the applicable vesting date.

2. Includes 811,691 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Mark Hair	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)